If you were wondering how the recent positive results from a stage 3 alz trial fit with this theory: "Interestingly, lecanemab, the anti-amyloid drug recently

If you were wondering how the recent positive results from a stage 3 alz trial fit with this theory: "Interestingly, lecanemab, the anti-amyloid drug recently reported as beneficial, does something that most other anti-amyloid treatments don't do in addition to reducing amyloid: it increases the levels of the soluble amyloid-beta," Espay said.